Navigation Links
Mystery behind Preeclampsia uncovered

Scientists have linked the rise in levels of S-nitrosoalbumin, a naturally occuring chemical found in the blood with Preeclampsia. This dangerous complication of pregnancy affects 10% of all first pregnancies. If untreated, this can worsen into a life threatening condition called Eclampsia in which a women has convulsive seizures during pregnancy. The research was led by Dr.Valerian E.Kagan of the University of Pittsburgh, Pennsylvania.

The investigators analyzed blood samples from 21 women who were diagnosed with preeclampsia and compared the results with samples from 21 healthy pregnant women and 12 non-pregnant women. Their findings are published in the June 8th issue of Circulation Research: Journal of the American Heart Association.

Normally, the body uses naturally produced nitric oxide (NO) to help keep blood vessels relaxed, which helps keep blood pressure in check in an effort to keep NO readily available, the body keeps a reserve of the chemical in the blood in the form of another chemical called S-nitrosoalbumin. In women with preeclampsia, the levels of S-nitrosoalbumin were 2 to 3 times higher than the other participances of the study. Also these women had low levels of vitamin C in their blood. Vitamin C helps break down the S-nitrosoalbumin to release nitric oxide into the bloodstream.

Dr. Kagan said future studies would focus on the possibilities of vitamin C reducing the risk of preeclampsia.
'"/>




Page: 1

Related medicine news :

1. Understanding The Mystery Behind Sleepless Nights
2. Mystery of nacrolepsy uncovered
3. Cholesterol Mystery Solved By Nobel Laureates
4. A Step Towards Unraveling The Schizophrenia And Depression Mystery
5. Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved
6. $2.4 Million Grant To Unravel The Mystery Of Language Recognition.
7. Mystery behind Brain activity during recalling events disentangled
8. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
9. Mystery Of The Placebo Effect, Yet To Be Solved
10. Dry Earwax Mystery Solved: Ear Wax Gene Identified
11. Mystery Behind The Déjà Vu Phenomenon Yet To Be Resolvd
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... 2016 , ... "FCPX Overlay Glare is a tool that utilizes light found ... or complicated compositing," said Christina Austin - CEO of Pixel Film Studios. , ... lights that simulates the look of a glare. Just drag and drop to ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... been featured in SuperbCrew magazine, a leading online tech news platform connecting technology ... now featured on SuperbCrew.com, explores the state of enterprise mobility security today, and ...
(Date:12/5/2016)... ... , ... “Epilepsy Awareness,” which can be found at the ... about epilepsy, bearing down on the social stigma and lack of public education ... within their lifetime. With such a large percentage of people affected, it’s critically ...
(Date:12/5/2016)... ... December 05, 2016 , ... Eating disorders are equal ... Castlewood Treatment Centers has always been to promote the power of recovery, and ... possible. In that spirit, Castlewood has announced two new hires, both Outreach Directors ...
(Date:12/5/2016)... Shrewsbury, PA (PRWEB) , ... December 05, 2016 , ... ... of necessity for the betterment of both the smaller rider and the horse. Smaller ... performance. The Saddle Sidekick is designed to fit over a properly fitted western saddle ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to ... Surgery Devices Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume ... - Canaloplasty Micro Catheters and Glaucoma Drainage Devices. ... data for each of these market segements, and global ...
(Date:12/5/2016)... -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ), the ... and manufacturing data that support SB-525, its gene therapy program ... of the American Society of Hematology (ASH) being held in ... 2016. "We have developed an improved gene therapy ... highly competitive, and we remain on track to file an ...
(Date:12/5/2016)... Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., a ... data from two Phase I trials evaluating its ... 58th annual meeting of the American Society of ... . The two datasets show encouraging efficacy ... leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell NHL), ...
Breaking Medicine Technology: